Early administration of Anti-SARS-CoV-2 Monoclonal Antibodies prevents severe Covid-19 in Kidney Transplant Patients
Description
CONCLUSION: The early use of MoAb in KTRs with a mild form of Covid-19 largely improved outcomes in KTRs.
